» Articles » PMID: 30214540

Menaquinone-4 Modulates the Expression Levels of Calcification-associated Factors to Inhibit Calcification of Rat Aortic Vascular Smooth Muscle Cells in a Dose-dependent Manner

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2018 Sep 15
PMID 30214540
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Vascular calcification (VC) caused by chronic kidney disease (CKD)-mineral and bone disorder is a common complication of CKD. Recent studies have demonstrated that menaquinone-4 (MK-4) is negativly associated with VC in patients with CKD. Furthermore, we have previously shown that runt-related transcription factor 2 (Runx2) is important in the phenotypic transformation process of rat vascular smooth muscle cells (VSMCs), which is the key step for the development of VC. The present study investigated the influence of MK-4 on the phenotypic transformation process of rat VSMCs in order to illustrate its role in the process of VC. Calcification assays were perfomed to access the calcified degree of rat VSMCs. Additionally, the genes and proteins related to phenotypic transformation were measured by reverse transcription-polymerase chain reaction and western blotting methods. It was revealed that calcium deposition in the cells was evidently increased with an addition of β-glycerophosphate (β-GP) and could be completely prevented by co-incubation with MK-4 in a dose-dependent manner. Furthermore, the expression of Runx2 in the β-GP-induced VSMCs was inhibited by MK-4. It was also revealed that the expression of SMAD1 and bone morphogenetic protein (BMP)-2 were decreased in the β-GP-induced VSMCs treated with MK-4 in a dose-dependent manner; however, the expression of SMAD7 was increased in the β-GP-induced VSMCs treated with MK-4 in a dose-dependent manner. These observations suggest that MK-4 reduces mineralization by regulating the BMP-2 signaling pathway in order to attenuate the expression of Runx2.

Citing Articles

Investigating the Effects and Mechanisms of Combined Vitamin D and K Supplementation in Postmenopausal Women: An Up-to-Date Comprehensive Review of Clinical Studies.

Rusu M, Bigman G, Ryan A, Popa D Nutrients. 2024; 16(14.

PMID: 39064799 PMC: 11279569. DOI: 10.3390/nu16142356.


Hypomethylation of the LncRNA H19 promoter accelerates osteogenic differentiation of vascular smooth muscle cells by activating the Erk1/2 pathways.

Wang T, Cheng M, Jin J, Bai Y, Zhang D, Zhang S J Int Med Res. 2024; 52(3):3000605241234567.

PMID: 38530015 PMC: 10966982. DOI: 10.1177/03000605241234567.


Role of vitamins beyond vitamin D in bone health and osteoporosis (Review).

Skalny A, Aschner M, Tsatsakis A, Rocha J, Santamaria A, Spandidos D Int J Mol Med. 2023; 53(1).

PMID: 38063255 PMC: 10712697. DOI: 10.3892/ijmm.2023.5333.


The biological responses of vitamin K2: A comprehensive review.

Yan Q, Zhang T, OConnor C, Barlow J, Walsh J, Scalabrino G Food Sci Nutr. 2023; 11(4):1634-1656.

PMID: 37051359 PMC: 10084986. DOI: 10.1002/fsn3.3213.


Roles of Nuclear Receptors in Vascular Calcification.

Chinetti G, Neels J Int J Mol Sci. 2021; 22(12).

PMID: 34204304 PMC: 8235358. DOI: 10.3390/ijms22126491.

References
1.
Bolasco P . Effects of the Use of Non-Calcium Phosphate Binders in the Control and Outcome of Vascular Calcifications: A Review of Clinical Trials on CKD Patients. Int J Nephrol. 2011; 2011:758450. PMC: 3118729. DOI: 10.4061/2011/758450. View

2.
Danilevicius C, Lopes J, Pereira R . Bone metabolism and vascular calcification. Braz J Med Biol Res. 2007; 40(4):435-42. DOI: 10.1590/s0100-879x2007000400001. View

3.
Chiba Y, Sakai H, Wachi H, Sugitani H, Seyama Y, Misawa M . Upregulation of rhoA mRNA in bronchial smooth muscle of antigen-induced airway hyperresponsive rats. J Smooth Muscle Res. 2004; 39(6):221-8. DOI: 10.1540/jsmr.39.221. View

4.
Li M, Wu P, Shao J, Ke Z, Li D, Wu J . Losartan Inhibits Vascular Calcification by Suppressing the BMP2 and Runx2 Expression in Rats In Vivo. Cardiovasc Toxicol. 2015; 16(2):172-81. DOI: 10.1007/s12012-015-9326-y. View

5.
Sun S, Guo H, Zhang J, Yu B, Sun K, Jin Q . BMP-2 and titanium particles synergistically activate osteoclast formation. Braz J Med Biol Res. 2014; 47(6):461-9. PMC: 4086172. DOI: 10.1590/1414-431x20132966. View